Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

被引:104
|
作者
Scalone, Luciana [1 ,2 ,3 ]
Ciampichini, Roberta [2 ]
Fagiuoli, Stefano [4 ]
Gardini, Ivan [5 ]
Fusco, Francesco [2 ]
Gaeta, Laura [4 ]
Del Prete, Anna [4 ]
Cesana, Giancarlo [1 ]
Mantovani, Lorenzo G. [2 ,6 ]
机构
[1] Univ Milano Bicocca, Res Ctr Publ Hlth, CESP, Milan, Italy
[2] CHARTA Fdn, Milan, Italy
[3] Fdn Charta, I-20122 Milan, Italy
[4] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[5] Patients Org EpaC ONLUS, Milan, Italy
[6] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy
关键词
Health-related quality of life (HRQoL); Chronic hepatic diseases; EQ-5D-3L; EQ-5D-5L; Psychometric performance; QUALITY-OF-LIFE; LIVER-DISEASE; SPANISH VERSION; 5-LEVEL VERSION; 3-LEVEL SYSTEM; CANDIDATES; UTILITIES; VALIDITY;
D O I
10.1007/s11136-012-0318-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To assess the performance of the EQ-5D-5L version compared with the standard EQ-5D-3L in a clinical setting targeted at patients with chronic hepatic diseases (CHDs). We introduced the 5L descriptive system into a cost-of-illness study involving patients with different CHDs. The patients completed a questionnaire including the two versions of the EQ-5D, together with other questions related to their condition. We tested the feasibility, the level of inconsistency, the redistribution properties among consistent responses, the ceiling effect, the discriminative power, and the convergent validity of the 5L compared with the 3L system. A total of 1,088 valid patients were recruited: 62 % male, 19-89 (median = 59) years old. Patients had chronic hepatitis from HCV (31.8 %) or HBV infections (29.3 %) or other causes (7.8 %), 20.4 % had cirrhosis, 11.9 % underwent liver transplantation, and 7.8 % had hepatic carcinoma. Less than 1 % of EQ-5D-5L were returned blank, and 1.6 % or less of missing values were calculated on the dimensions of the partially completed questionnaires. The proportion and weight of inconsistent responses (i.e., 3L responses that were at least two levels away from the 5L responses) was 2.9 % and 1.2 on average, respectively. Regarding redistribution, 57-65 % of the patients answering level 2 with the 3L version redistributed their responses to levels 2 or 4 with the 5L version. A relative 7 % reduction of the ceiling effect was found. Furthermore, the absolute informativity increased but the relative informativity slightly decreased in every domain, and the convergent validity with the VAS improved. In a clinical setting involving CHD patients, the EQ-5D-5L was shown to be feasible and with promising levels of performance. Our findings suggest that the 5L performs better in at least some of the properties analyzed, and encourage further research to also test other psychometric properties of this new version of the EQ-5D.
引用
下载
收藏
页码:1707 / 1716
页数:10
相关论文
共 50 条
  • [21] Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
    Nora Wille
    Xavier Badia
    Gouke Bonsel
    Kristina Burström
    Gulia Cavrini
    Nancy Devlin
    Ann-Charlotte Egmar
    Wolfgang Greiner
    Narcis Gusi
    Michael Herdman
    Jennifer Jelsma
    Paul Kind
    Luciana Scalone
    Ulrike Ravens-Sieberer
    Quality of Life Research, 2010, 19 : 875 - 886
  • [22] Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
    Wille, Nora
    Badia, Xavier
    Bonsel, Gouke
    Burstrom, Kristina
    Cavrini, Gulia
    Devlin, Nancy
    Egmar, Ann-Charlotte
    Greiner, Wolfgang
    Gusi, Narcis
    Herdman, Michael
    Jelsma, Jennifer
    Kind, Paul
    Scalone, Luciana
    Ravens-Sieberer, Ulrike
    QUALITY OF LIFE RESEARCH, 2010, 19 (06) : 875 - 886
  • [23] Contribution for the Validation of the Portuguese Version of EQ-5D
    Ferreira, Pedro Lopes
    Ferreira, Lara Noronha
    Pereira, Luis Nobre
    ACTA MEDICA PORTUGUESA, 2013, 26 (06): : 664 - 675
  • [24] A five-level version of EQ-5D
    Kind, P
    Macran, S
    VALUE IN HEALTH, 2004, 7 (06) : 650 - 650
  • [25] Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
    Golicki, Dominik
    Niewada, Maciej
    Karlinska, Anna
    Buczek, Julia
    Kobayashi, Adam
    Janssen, M. F.
    Pickard, A. Simon
    QUALITY OF LIFE RESEARCH, 2015, 24 (06) : 1555 - 1563
  • [26] Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
    Dominik Golicki
    Maciej Niewada
    Anna Karlińska
    Julia Buczek
    Adam Kobayashi
    M. F. Janssen
    A. Simon Pickard
    Quality of Life Research, 2015, 24 : 1555 - 1563
  • [27] COMPARING THE EQ-5D-3L AND EQ-5D-5L IN A COHORT OF CANCER PATIENTS
    Lorgelly, P.
    Cubi-Molla, P.
    Pennington, M. W.
    Norman, R.
    VALUE IN HEALTH, 2018, 21 : S226 - S226
  • [28] The EQ-5D and the EuroQol Group
    Lloyd, Andrew
    Pickard, A. Simon
    VALUE IN HEALTH, 2019, 22 (01) : 21 - 22
  • [29] Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease
    Gandhi, Mihir
    San Tan, Ru
    Lim, Shir Lynn
    Rand, Kim
    Lam, Carolyn S. P.
    Luo, Nan
    Cheung, Yin Bun
    VALUE IN HEALTH, 2022, 25 (03) : 451 - 460
  • [30] The valuation of the EQ-5D in Portugal
    Ferreira, Lara N.
    Ferreira, Pedro L.
    Pereira, Luis N.
    Oppe, Mark
    QUALITY OF LIFE RESEARCH, 2014, 23 (02) : 413 - 423